Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-27

FDA Approved: BUPRENORPHINE — Original Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

FDA approves Rhodes Pharmaceuticals L.P.'s original ANDA application for a generic buprenorphine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

ORIG AP for BUPRENORPHINE (BUPRENORPHINE)